Building on the advances made during the p... The pharmaceutical industry has made significant advances in collaboration over the past two years, and I have seen many examples amongst Pistoia Alliance members of the power of cooperative working. … more ➔
Vaccines burst 2021 biotech bubbleDespite a couple of notable ‘firsts’ for European public biotech financing, biotech’s COVID-19 bubble may be about to burst. Virus fears pushed both private and public investors toward biotech, but vaccination … more ➔
Supporting ulta-rare diseases Medicines for rare and paediatric diseases have been successfully enabled through the EU’s incentives framework. The number of medicines in development has risen significantly since the introduction … more ➔
mRNA – delivering on the promisesThe past two years could be called the years of messenger RNA (mRNA) technology, with two major biotech companies, BioNTech and Moderna, playing a crucial role in the development of vaccines against … more ➔
Europe needs strong incentives for private... The COVID-19 pandemic has demonstrated how vulnerable human beings and societies are to a new infectious disease, and how important the life science industry is to come up with diagnostic and therapeutic … more ➔
Variants will drive long-term COVID-19 vac...New entrants and variants will be main drivers of the COVID-19 vaccine market as supply gradually begins to catch up with demand. more ➔
Current EU GMO legislation is not fit for... The Commission study on Novel Genomic Techniques (NGTs) underlines that plants resulting from NGTs have the potential to contribute to a more sustainable food system and support the objectives of the … more ➔
Providing access to Covid-19 medicines and... IP U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents: President Joe Biden in May threw his support behind waiving intellectual property rights for COVID-19 vaccines … more ➔
European biotechs: Such a long waitEuropean biotechs have been longly undervalued. In the wake of the COVID-19 pandemic, some of them took off. They will have to prove their value in a post-COVID era. However, Europe is there. more ➔
Harmonisation of patent law without the UP... Hague Court of Appeal (CoA) sets Dutch approach to the doctrine equivalence reversing District Court, handing Eli Lilly another win in its pan-European battle over infringement of its pemetrexed patents … more ➔
